Technical Analysis for VANI - Vivani Medical, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.62 | -4.38% | -0.07 |
VANI closed down 2.02 percent on Thursday, April 25, 2024, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | -4.38% | |
Wide Bands | Range Expansion | -4.38% | |
Oversold Stochastic | Weakness | -4.38% | |
180 Bearish Setup | Bearish Swing Setup | -6.31% | |
Narrow Range Bar | Range Contraction | -6.31% | |
Lower Bollinger Band Walk | Weakness | -6.31% | |
Inside Day | Range Contraction | -6.31% | |
Oversold Stochastic | Weakness | -6.31% | |
Bullish Engulfing | Bullish | -9.96% | |
Stochastic Buy Signal | Bullish | -9.96% |
Alert | Time |
---|---|
Down 3% | about 3 hours ago |
Fell Below Previous Day's Low | about 3 hours ago |
Lower Bollinger Band Support | about 3 hours ago |
Down 2 % | about 4 hours ago |
Down 1% | about 4 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Vivani Medical, Inc. develops and commercializes drug and device implants to treat patients with chronic diseases with unmet medical need. Its lead product candidate is NPM-119, a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes. The company is based in Sylmar, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Organ Systems Diabetes Chronic Disease Implant Peptide Hormones Glucagon Like Peptide 1
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Organ Systems Diabetes Chronic Disease Implant Peptide Hormones Glucagon Like Peptide 1
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.8 |
52 Week Low | 0.84 |
Average Volume | 3,895,871 |
200-Day Moving Average | 1.25 |
50-Day Moving Average | 1.91 |
20-Day Moving Average | 1.92 |
10-Day Moving Average | 1.83 |
Average True Range | 0.16 |
RSI (14) | 41.86 |
ADX | 29.28 |
+DI | 26.49 |
-DI | 25.56 |
Chandelier Exit (Long, 3 ATRs) | 1.75 |
Chandelier Exit (Short, 3 ATRs) | 2.08 |
Upper Bollinger Bands | 2.21 |
Lower Bollinger Band | 1.63 |
Percent B (%b) | 0.12 |
BandWidth | 30.28 |
MACD Line | -0.05 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0409 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.81 | ||||
Resistance 3 (R3) | 1.81 | 1.76 | 1.79 | ||
Resistance 2 (R2) | 1.76 | 1.73 | 1.76 | 1.79 | |
Resistance 1 (R1) | 1.73 | 1.71 | 1.71 | 1.73 | 1.78 |
Pivot Point | 1.68 | 1.68 | 1.67 | 1.69 | 1.68 |
Support 1 (S1) | 1.65 | 1.65 | 1.63 | 1.66 | 1.61 |
Support 2 (S2) | 1.60 | 1.63 | 1.61 | 1.60 | |
Support 3 (S3) | 1.57 | 1.60 | 1.60 | ||
Support 4 (S4) | 1.58 |